EXEL
Exelixis, Inc. · Healthcare
CSO, EVP Disc, Trans Research Dana Aftab sold $3.4M of Exelixis, Inc.
Sold$3,394,510
$35.00Price
96,986Shares
−16%Stake
What EXEL did after the filing
- The stock from Thu, Nov 7 close, $35.80
- −7.0%
- S&P 500, same days
- −0.4%
Measured over 30 trading days, to the Dec 20 close.
Traded Tue, Nov 5. Filed Thu, Nov 7, 2:44 PM ET, during the session. Returns use the Nov 7 close and the Dec 20 close. Not investment advice.